Patent 6080407 Issued on June 27, 2000. Estimated Expiration Date: June 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
424/158.1, Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, vascular permeability factor, etc.); or binds serum protein, plasma protein, fibrin, or enzyme424/145.1, Binds hormone or other secreted growth regulatory factor, differentiation factor, or intercellular mediator (e.g., cytokine, etc.); or binds serum protein, plasma protein (e.g., tPA, etc.), or fibrin424/198.1, Hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, neurotransmitter, or fragment thereof514/169, Cyclopentanohydrophenanthrene ring system DOAI530/387.3, Chimeric, mutated, or recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobulin fusion protein, etc.)530/388.23, Binds lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, or intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)530/389.2Binds hormone, lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, glucagon, cardiodilatin, interleukin, interferon, norepinephrine, epinephrine, acetylcholine, etc.)
The present invention relates to compositions and methods for inhibiting the release and/or biological activity of migration inhibitory factor (MIF). In particular, the invention relates to the uses of such compositions and methods for the treatment of various conditions involving cytokine-mediated toxicity, which include, but are not limited to shock, inflammation, graft versus host disease, and/or autoimmune diseases.
Other References
Natanson et al., Annals of Internal Medicine, vol. 120: 771-783, Jan. 1994
Kuby, Immunology, W.H. Freeman & Co., New York, pp. 357-358 and 378-379, 1992
Taber Cyclopedic Medical Dictionary, F.A. Davis Co., Philadelphia, 14th Edition p. 609, 1984
Dorland's Illustrated Medical Dictionary, WB Saunders Co. Philadelphia, p. 387 (27th Edition) 1988
David et al., "Delayed Hypersensitivity in Vitro: Its Mediation By Cell Free Substances Formed By Lymphoid Cell-Antigen Interaction", Pathology 56:72-77 (1966)
Bennett and Bloom, "Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity", Science 153:80-82 (1966)
Nathan et al., "Alterations of Macrophage by Mediators From Lymphocytes", J Exp Medicine 133:1356-1376 (1971)
Nathan et al., "Characterization of a Lymphocyte Factor Which Alters Macrophage Functions", J Exp Medicine 137:275-288 (1973)
Kohler and Milstein, "Continuous Culture of Fused Cells Secreting Antibody of Predefined Specifity", Nature 256:495-497 (1975)
Weiser et al., "Studies of Human Migration Inhibitory Factor: Characterization of Three Molecular Species", J Immunol 126:1958-1962 (1981)
Kaiser and Kezdy, "Secondary Structures of Proteins and Peptides in Amphiphilic Environments (A Review)", Proc Natl Acad Sci USA 80:1137-1143 (1983)
Peck, "The Elisa Method for Quantitation of Macrophage Migration from Agarose Microdroplets", J Immunol Methods 64:179-187 (1983)
Morrison et al., "Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains with Human Constant Region Domains", Proc Natl Acad Sci 81:6851-6855 (1984)
Sprung et al., "The Effects of High Dose Corticosteroids in Patients with Septic Shock", New Eng Eng J Med 311:1137-1143 (1984)
Beutler et al., "Purification of Catechin, A Lipoprotein Lipase-Suppressing Hormone Secreted by Endotoxin-Induced Raw 264.7 Cells", J Exp Med 161:984-995 (1985)
Erne et al., "Preferred Confirmation, Orientation, and Accumulation of Dynorphin A-(1-13)-Tridecapeptides on the Surfaces of Neutral Lipid Membranes", Biochemistry 24:4263-4265 (1985)
Beutler et al., "Catechin/Tumor Necrosis Factor: Production, Distribution, and Metabolic Fate in Vivo", J Immunol 135:3972-3977 (1985)
Suzuki et al., "Pituitary-Dependent and -Independent Secretion of CS Caused by Bacterial Endotoxin in Rats", Am J Physiol 250:E470-E474 (1986)
Liu and Too A Monoclonal Antibody Specific for a Monocyte-Macrophage Membrane Component Blocks the Human Monocyte Response to Migration Inhibitory Factor, J Immuno 137:448-455 (1986)
Thomas and Cappechi, "Site-Directed Mutagen by Gene Targeting in Mouse Embryo-Derived Stem Cells", Cell 51:503-512 (1987)
Bone et al., "A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock", New Eng J Med 311:1137-1141 (1987)
Ding et al., "Release of Reactive Nitrogen Intermediates and Reactive Oxygen Intermediates From Mouse Peritoneal Macrophages", J Immunol 141:2407-2413 (1988)
Smith, "Interleukin 2: Inception, Impact, and Implications", Science 240:1169-1176 (1988)
Michie et al., "Detection of Circulating Tumor Factor After Endotoxin Administration", New Eng J Med 318:1481-1486 (1988)
Wolpe et al., "Macrophages Secrete a Novel Heparin- Binding Protein With Imflammatory and Neutrophil Chemokinetic Properties", J Exp Medicine 167:570-581 (1988)
Huse et al., "Generation of a Large Combinatorial Library of the Immunoglobin Repertoire in Phage Lambda", Science 246:1275-1281 (1989)
Sternberg et al., "Inflammatory Mediator-Induced Hypothalamic-Pituitary-Adrenal Axis Activation is Defective in Streptococcal Cell Wall Arthritis-Susceptible Lewis Rats", Proc Natl Acad Sci USA 86:2374-2378 (1989)
Weiser et al., "Molecular Cloning of cDNA Encoding Human Macrophage Migration Inhibitory Factor", Proc Natl Acad Sci 86:7522-7526 (1989)
Zuckerman et al., "Differential Regulation of Lipopolysaccharide-Induced Interleukin 1 and Tumor Necrosis Factor Synthesis: Effects of Endogenous and Exogenous Glucocorticoids and the Role of the Pituitary-Adrenal Axis", Eur J Immunol 19:301-305 (1989)
Uhlmann and Peyman, "Antisense Oligonucleotides: A New Therapeutic Principle", Chem Rev 90:543-584 (1990)
Buhler et al., "Rabbit ଲ-Casein Promoter Directs Secretion of Human Interleukin-2 into the Milk of Transgenic Rabbits", Biotechnology 8;140-143 (1990)
Edwards III et al., "Hypophysectomy Inhibits the Synthesis of Tumor Necrosis Factor by Rat Macrophages: Partial Restoration by Exogenous Growth Hormone or Interferon γ", Endocrinol 128:989-986 (1991)
Dinarello, "The Proinflammatory Cytokines Interleukin-1 and Tumor Necrosis Factor and Treatment of the Septic Shock Symdrome", J Infect Dis 163:1177-1184 (1991)
Edwards III et al, "The Pituitary is Required for Protection Against Lethal Effects of Salmonella Typhimurium", Proc Natl Acad Sci USA 88:2274-2277 (1991)
Silverstien et al., "Hydrazine Sulfate Protects D-Galactosamine-Sensitized Mice Against Endotoxin and Tumor Necrosis Factor.backslash.Cachetin Lethality: Evidence of a Role for the Pituitary", J Exp Med 173:357-365 (1991)
Lam et al., "A New Type of Synthetic Peptide Library for Identifying Ligand Binding Activity", Nature 354:82-84 (1991)
Fung-Leung et al., "CD8 is Needed for the Development of Cytotoxic T-Cells by not Helper T-Cells", Cell 65:443-449 (1991)
Holmes et al., "Structure and Functional Expression of a Human Interleukin-8 Receptor", Science 253:1278-1280 (1991)
Weiser et al., "Human Recombinant Migration Inhibitory Factor Activates Human Macrophages to Kill Leishmania Donovani", J Immunol 147:2006-2011 (1991)
Pozzi et al., "Human Recombianant Migration Inhibitory Factor Activates Human Macrophages to Kill Tumor Cells", Cellular Immunol 145:372-379 (1992)
Fry et al., "Solution Structures of Cyclic and Dicylic Anologues of Growth Hormone Releasing Factor as Determined by Two-Dimensional NMR and CD Spectroscopies and Constrained Molecular Dynamics", Biopolymer 32:649-666 (1992)
Sigal and Dumont, "Cyclosporin A, FK-506, and Rapamycin: Pharmacologic Probes of Lymphocyte Signal Transduction", Ann Rev Immunol 10:519-560 (1992)
Blocki et al., "Rat Liver Protein Linking Chemical and Immunological Detoxification Systems", Nature 360:269-270 (1992)
Vassalli, "The Pathophysiology of Tumor Necrosis Factors", Ann Rev Immunol 10:411-452 (1992)
Weiser et al., "Recombinant Human Migration Inhibitory Factor has Adjuvant Activity", Procl Natl Acad Sci USA 89:8049-8052 (1992)
Lanahan et al., "Growth Factor-Induced Delayed Early Resonse Genes", Mol Cell Biol 12:3919-3929 (1992)
Sherry et al., "Identification of Cyclophilin as a Proinflammatory Secretory Product of Lipopolycaccharide-Activated Macrophages", Proc Natl Acad Sci USA 89:3511-3515 (1992)
Bernhagen et al., "Identification of Macrophage Migration Inhibitory Factor (MIF) as an LPS-Induced Pituitary Protein in Vitro and in Vivo", J Cell Biochem. Supplement 1 7B, Abstract E306 (1993)
Wistow et al., "A Macrophage Migration Inhibitory Factor is Expressed in the Differentiating Cells of the Eye Lens", Proc Natl Acad Sci USA 90:1272-1275 (1993)
Bernhagen et al., "MIF is a Pituitary-Derived Cytokine that Potentiates Lethal Endotoxaemia", Nature 365:756-759 (1993)
Mikayama et al., "Molecular Cloning and Functional Expression of a cDNA Encoding Glycosylation-Inhibiting Factor", Proc Natl Acad Sci USA 89:10056-10060 (1993)
Cunha et al., "Recombinant Migration Inhibitory Factor Induces Nitric Oxide Synthase in Murine Macrophages", J Immunol 150:1908-1912 (1993
June 27, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
